2014
Smoking and mental illness in the US population
Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the US population. Tobacco Control 2014, 23: e147. PMID: 24727731, PMCID: PMC4201650, DOI: 10.1136/tobaccocontrol-2013-051466.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCross-Sectional StudiesDiagnostic and Statistical Manual of Mental DisordersFemaleHealth Status DisparitiesHumansLongitudinal StudiesMaleMental DisordersMental Health ServicesMiddle AgedPrevalenceSmokingSmoking CessationSocioeconomic FactorsTobacco Use DisorderYoung AdultConceptsPsychiatric diagnosisCessation ratesQuit ratesSpecific diagnosisMental health service useEstimates of smokingHealth service useCurrent psychiatric diagnosisSpecific psychiatric diagnosesNational Epidemiologic SurveyTimes greater oddsPast-year psychiatric diagnosisHeavy smokingPsychiatric comorbiditySmoking ratesTobacco useTreatment useComorbid disordersSmokingGreater prevalenceService useEpidemiologic SurveyGreater oddsCohort surveyUS population
2009
Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers
McKee SA, Harrison EL, O'Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM, Picciotto MR, Petrakis IL, Estevez N, Balchunas E. Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers. Biological Psychiatry 2009, 66: 185-190. PMID: 19249750, PMCID: PMC2863311, DOI: 10.1016/j.biopsych.2009.01.029.Peer-Reviewed Original ResearchConceptsHeavy drinking smokersSelf-administration periodAlcohol consumptionPartial nicotinic agonistPlacebo-controlled investigationEffects of vareniclineReduced ethanol intakeAlcohol Self-AdministrationAlcohol use disorderNicotinic acetylcholine receptorsMedication pretreatmentAdverse eventsNumber of drinksPreclinical evidenceAdditional drinkEthanol intakeTobacco dependenceDaily smokersPriming doseVareniclineComorbid disordersNicotinic agonistsUse disordersPriming drinkPotential treatment